BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alanazi MM, Alaa E, Alsaif NA, Obaidullah AJ, Alkahtani HM, Al-Mehizia AA, Alsubaie SM, Taghour MS, Eissa IH. Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and in silico studies. J Enzyme Inhib Med Chem 2021;36:1732-50. [PMID: 34325596 DOI: 10.1080/14756366.2021.1945591] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Alesawy MS, Elkaeed EB, Alsfouk AA, Metwaly AM, Eissa IH. In Silico Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies. Molecules 2021;26:6593. [PMID: 34771004 DOI: 10.3390/molecules26216593] [Reference Citation Analysis]
2 El-Adl K, Sakr HM, Yousef RG, Mehany ABM, Abulkhair HS, Eissa IH. New quinoxalin-2(1H)-one-derived VEGFR-2 inhibitors: Design, synthesis, in vitro anticancer evaluations, in silico ADMET, and docking studies. Arch Pharm (Weinheim) 2022;:e2200048. [PMID: 35437829 DOI: 10.1002/ardp.202200048] [Reference Citation Analysis]
3 Alsaif NA, Mahdy HA, Alanazi MM, Obaidullah AJ, Alkahtani HM, Al-Hossaini AM, Al-Mehizi AA, Elwan A, Taghour MS. Targeting VEGFR-2 by new quinoxaline derivatives: Design, synthesis, antiproliferative assay, apoptosis induction, and in silico studies. Arch Pharm (Weinheim) 2021;:e2100359. [PMID: 34862634 DOI: 10.1002/ardp.202100359] [Reference Citation Analysis]
4 Zengin M, Unsal Tan O, Arafa RK, Balkan A. Design and Synthesis of New 2-Oxoquinoxalinyl-1,2,4-triazoles as Antitumor VEGFR-2 Inhibitors. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yousef RG, Eldehna WM, Elwan A, Abdelaziz AS, Mehany ABM, Gobaara IMM, Alsfouk BA, Elkaeed EB, Metwaly AM, Eissa IH. Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2. Molecules 2022;27:4079. [DOI: 10.3390/molecules27134079] [Reference Citation Analysis]
6 Belal A, Abdel Gawad NM, Mehany ABM, Abourehab MAS, Elkady H, Al-Karmalawy AA, Ismael AS. Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine derivatives as potent EGFR/CDK2 inhibitors. J Enzyme Inhib Med Chem 2022;37:1884-902. [PMID: 35801486 DOI: 10.1080/14756366.2022.2096019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yousef RG, Ibrahim A, Khalifa MM, Eldehna WM, Gobaara IMM, Mehany ABM, Elkaeed EB, Alsfouk AA, Metwaly AM, Eissa IH. Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies. J Enzyme Inhib Med Chem 2022;37:1389-403. [PMID: 35577416 DOI: 10.1080/14756366.2022.2070744] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Eissa IH, Khalifa MM, Elkaeed EB, Hafez EE, Alsfouk AA, Metwaly AM. In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10. Molecules 2021;26:6151. [PMID: 34684735 DOI: 10.3390/molecules26206151] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Azab AE, Alesawy MS, Eldehna WM, Elwan A, Eissa IH. New [1,2,4]triazolo[4,3-c]quinazoline derivatives as vascular endothelial growth factor receptor-2 inhibitors and apoptosis inducers: Design, synthesis, docking, and antiproliferative evaluation. Arch Pharm (Weinheim) 2022;:e2200133. [PMID: 35822666 DOI: 10.1002/ardp.202200133] [Reference Citation Analysis]
10 Elkaeed EB, Elkady H, Belal A, Alsfouk BA, Ibrahim TH, Abdelmoaty M, Arafa RK, Metwaly AM, Eissa IH. Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs. Processes 2022;10:530. [DOI: 10.3390/pr10030530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
11 Elkaeed EB, Youssef FS, Eissa IH, Elkady H, Alsfouk AA, Ashour ML, El Hassab MA, Abou-seri SM, Metwaly AM. Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease. IJMS 2022;23:6912. [DOI: 10.3390/ijms23136912] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]